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Abstract 
As a result of the ongoing Syrian civil war, almost 3 million refugees moved to Turkey since 2011 because of security 
reasons. However, the government operated refugee camps have been largely inadequate to accommodate this huge 
number of refugees. Therefore, almost 91% of the Syrian refugees live out of government-operated camps. According 
to a Turkish Disaster and Emergency Management Agency (AFAD) report, 45.4% of the children under 5 years old 
who live out of camps are not vaccinated against polio. This presents a serious health threat to the local population 
and the whole region. In order to deal with this potential risk, local vaccine distribution strategies that encourage 
vaccination should be developed for the cities that are close to Syrian border. We develop a mathematical model with 
which we determine the optimal number of polio vaccines that needs to be administered for each age group and the 
region considering the vaccination history of individuals. Different vaccination strategies (i) by age, (ii) by region, 
and (iii) by age-population are compared for cost effectiveness. 
Keywords 
Vaccine distribution, polio, mixed integer programming 
1. Introduction
As a result of increasingly worsening humanitarian conditions in Syria due to the civil war, the number of refugees in 
Turkey reached almost 3 million. Turkish government set up 21 government operated camps to host the refuges. 
However, the total capacity of those camps is not enough to accommodate the massive number of refugees. 
Consequently, there are many unregistered Syrian who are in border provinces of Turkey, including Hatay, Sanliurfa, 
Gaziantep, and Adana.  Disaster and Emergency Management Agency in Turkey (AFAD) reports that almost 91% of 
the refugees live out of the camps. The fact that majority of the refugees are not accommodated in the camps presents 
health risks for the population living in the region because of the difficulties in medical screening of refugees and 
related record keeping [1]. Due to war conditions in Syria, the routine immunization activities are interrupted, and 
most refugees do not have medical records. Moreover, worsening humanitarian conditions increase the spread of 
infectious diseases such as polio, measles, and chicken pox. According to an AFAD report, only 45% of the children 
are vaccinated against polio and measles, and this ratio dramatically decreases to 25% for those children who live out 
of camps. Having national borders with countries that have low population immunization and the large sudden 
refugee movements substantially elevated the risk of spread of the infectious diseases within Turkey. Attesting to this, 
diseases that have been eradicated started to appear in Turkey. For example, in 2002, Turkey has received a certificate 
from World Health Organization for successful eradication of the wild polio virus and ensuring a poliomyelitis free 
region [2]. However, due to the occurrence of three polio cases in Turkey and Syria in 2015 [3] and movements of a 
large number of Syrian refugees are threats to sudden polio outbreaks. In order to fully immunize the population 
against such sudden outbreaks, vaccination is an effective strategy [4]. 
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The problem is to allocate and distribute the optimal number of polio vaccines throughout Turkey in order to mitigate 
the risk of an outbreak. In the literature, although not specific for the polio case, there are studies on the vaccine 
distribution and allocation problem for infectious diseases. Jacobson et al. [5] consider the problem of quantity 
decision for vaccine procurement for a set of childhood diseases. They propose an integer linear programming model 
to minimize the cost of vaccine administration based on vaccine types and set of available vaccine combinations. 
Smalley et al. [6] consider the problem of optimal allocation of vaccine distribution strategies to decrease the cholera 
cases in Bangladesh. Their mixed-integer programming model answers where, when, and in what quantity vaccines 
are needed to minimize the disease incidences. What-if analysis are performed to evaluate cost comparison of age, 
region and age-region strategies. Duijzer et al. [7] review the vaccine supply chain studies by classifying them in 
terms of product (vaccine type), production (the required dose to provide protection against disease), allocation and 
distribution of vaccines (e.g., inventory control, facility location selection, and supply logistics of a perishable 
product). They analyze extant studies for existing and sudden outbreaks in developing countries. The study concludes 
that there is a need for operation research/operation management community to develop and analyze scheduling 
problems for the vaccination policies for children. There are also studies that focus on the vaccine supply chain 
performance in terms of vaccine availability, cost effectiveness, protected population, morality, and impact of 
redesigning the radical distance chains to eliminate storage locations [8-10].  
The objective of this study is to develop a mathematical model to determine the optimal number of polio vaccines to 
be administered to individuals who live in highly populated refugee-dense regions. The proposed mathematical model 
maximizes the percentage of protected population against polio under different budget constraints.  We analyze the 
cost effectiveness of the age-, region-, and age-population-based distribution strategies to assist the healthcare 
decision makers. The problem is unique and timely as it is inspired by a real health threat for children. Our work 
supports the development of a solution strategy to eradicate the polio virus from the region given the complexities of 
the refugee problem.  
2. Problem statement
We propose a mixed integer linear programming model by which optimal vaccine quantities for multiple regions and 
age groups are determined to maximize the number of vaccinated population against polio. We apply this model to 
five cities that have the highest refugee population. Each of these five cities are categorized into two groups, namely 
high risk and low risk groups with regards to the age of the population. High risk group includes children who are 
under 6 years old (0-59 month), and the low risk group contains the individuals aged between 10 and 12. Like many 
studies in the medical literature [7], we consider vaccine allocation strategies over age groups and pay the highest 
attention to children due to their vulnerability for infectious diseases. The four cities out of five have the government 
operated refugee camps. Since it is comparatively easier to perform medical screening and to administer the missed 
vaccine doses, the ratio of the vaccinated population against polio in the camps are lower, 25% vs 45% [1]. Moreover 
the dose and the type of the polio vaccine (OPV- live attenuated oral polio vaccine, IPV-inactivated polio vaccine) 
differ with respect to age of the individual and whether the individual is previously vaccinated. Thus, the cost of 
vaccination depends on the age and the vaccination history of the individuals.  Table 1 lists the vaccine types that 
need to be administered and vaccination costs for various age and vaccination histories. Two doses OPV need to be 
administered to the local population who are under 6 years old, and the time between administration of doses must be 
at least one month [11]. Children, who are under 6 years old and haven’t been vaccinated before, need to have three 
doses of IPV. The time interval between the 1st dose and the 2nd dose must be at least 2 months, and the 3rd dose must 
be administered 8 months after the 2nd dose. Only one dose of IPV needs to be administered to the children of ages 10 
to 12 years old, who had previous vaccine doses [11]. Three doses of OPV need to be administered to 10 to 12 year 
old children, who have not been vaccinated before. There must be one month between 1st and the 2nd dose. The 3rd 
dose must be administered 8 months after the 2nd dose. We assume that each vaccinated individual receives the 
required doses in the same year. Vaccination cost includes the cost of vaccine, cost of freight (0.25 US$ [6]) and cost 
of delivery (0.3 US$ [6]) times the required number of doses. OPV costs comparatively less than IPV, 0.15 US$ 
versus 1.00 US$ [4]. Table 2 presents the population of five cities where the refugees are located along with age and 
type of accommodation information (i.e., inside-camps vs. outside-camps). 
Table 1: Vaccine types, dose and costs for individuals under different vaccination histories 
Vaccinated before Not vaccinated before 
Vaccine type and dose Vaccination cost Vaccine type and dose Vaccination cost 
Under 6 years old 2 dose OPV 1.40 US$ 3 dose IPV 4.65 US$ 
Above 6 years old 1 dose IPV 1.55 US$ 3 dose OPV 2.10 US$ 
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Table 2: The 2017 population of the five cities that have the highest refugee population based on age, region, and 
vaccination history, adopted from [1, 12] 
Cities 
Population of the refugees Population of the refugees not vaccinated against polio 
Refugees live in camps Refugees out of camps Refugees live in camps Refugees out of camps 
6- 6+ 6- 6+ 6- 6+ 6- 6+ 
Istanbul  0 0 70,396 138,955 0 0 31,678 62,529 
Sanliurfa 16,266 38,758 46,522 91,830 4,066 9,689 20,935 41,323 
Hatay 2,851 6,794 53,857 106,308 712 1,698 24,235 47,838 
Gaziantep 5,878 14,008 42,738 84,360 1,469 3,502 19,232 37,962 
Adana 86 205 23,181 45,758 21 51 10,431 20,591 
*6- refers to the individuals under 6 years old, where 6+ shows the individuals between 6 and 12 years old 
 
The problem of deciding optimal number of vaccines for each age and location considering the budget limit is 
modeled by a mixed integer linear programming model. The sets, parameters, variables of the model are listed below. 
Sets and indices 
A                 Set of age groups, A={0-59 month, 59+ month} 
C Set of cities, C={ Istanbul, Sanliurfa, Hatay, Gaziantep, Adana} 
H    Vaccination history, VH={ Vaccinated local population, Non-vaccinated population inside camps, 
Non-vaccinated population outside camps 
Parameters 
cahpop : Population of city c, age group a with vaccination history h 
ahm : Vaccination cost of individual at age a with vaccination history h 
HRB: Minimum ratio of the individuals that needs to be vaccinated at high risk age group (age 6-) 
LRB: Minimum ratio of the individuals that needs to be vaccinated at low risk age group (age 6+) 
CLc: Minimum number of individuals that needs to be vaccinated in each location 
:R  Unit overstock cost, :W  Unit shortage cost, B: Vaccination budget 
Variables 
:cahV  Number of individuals vaccinated in location c, age group a with vaccination history h 
:oC  Total overstock cost :uC
 
Total shortage cost :NV  Total number of individuals vaccinated 
The mixed integer programming model is presented in Equations (1-9). Objective function in Equation (1) maximizes 
the number of individuals vaccinated against polio. Constraint (2) ensures that the vaccination budget cannot be 
exceeded. Equation (3) shows the calculation of overstocking cost, where Equation (4) presents the calculation of 
shortage cost. Constraint (5) states that the number of vaccinated individuals in location c, age group a, and that have 
vaccination history h does not exceed the population in that group. Vaccination history shows whether the individual 
is vaccinated or not vaccinated against polio. We classify this indicator variable into three to represent the individuals 
who are vaccinated, individuals who are not vaccinated and live inside camps, and individuals who are not vaccinated 
and live outside of camps. Individuals that have missing doses of polio vaccine are considered as if they are not 
vaccinated. With regards to children’s vaccination history, the vaccine dose, type, and thus the vaccination costs 
differ. Constraint (6) ensures that minimum ratio of vaccinated individuals in location c, at high risk age group, and 
vaccination history h must be greater than HRB. Constraint (7) ensures that minimum ratio of vaccinated individuals 
in location c, at low risk age group, and vaccine history h must be greater than LRB. Constraints (6) and (7) are 
included to prioritize the high risk age group against others. Constraint (8) states a lower bound for each location c to 
determine the number of population members to be vaccinated in location c. Constraint (9) ensures that the number of 
vaccinated individuals must be a positive integer number.   
max cah
c C a A h H
NV V
  
  (1) 
s.t.  
. cah ah o u
c C a A h H
V m C C B
  
    (2) 
o c cah
c C c C a A h H
C R CL V
   
 
   
 
   (3) 
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u cah cah
c C a A h H c C a A h H
C W pop V
     
 
   
 
   (4) 
               ,  ,  cah cah cV po Cp a A h H     (5) 
.       ,  {0-59 month},  cah cahV pop HRB c C a h H      (6) 
.        ,  {59  month},  cah cahV pop LRB c C a h H
      (7) 
          cah c
a A h H
V CL c C
 
    (8) 
                      ,  ,  cahV c C a A h H
      (9) 
  
3. Numerical study 
In this part of the study, we determine the optimal number of population that should be vaccinated against polio, and 
compare vaccination strategies in terms of age and regional priority policies. We perform cost effectiveness 
comparisons for each strategy and provide a decision support system that could help health care decision makers. 
Cost effectiveness of vaccination of the total population of children younger than 6 years old, and vaccination of only 
refugees are compared in the first part of the numerical study. Different lower bounds on the minimum number of 
vaccines to be administered are compared to perform a trade-off analysis between cost and number of vaccinated 
individuals. Table 3 presents the optimal number of vaccines and its cost according to varying bounds on the number 
of individuals to be vaccinated in high and low risk age groups. The first row shows a baseline for the comparison of 
vaccination costs and the vaccine quantities. Even if the local population is vaccinated against polio at a ratio of 96% 
[3], the refugees with missing doses of polio vaccine or the refugees that have not been vaccinated at all present 
health risks for the whole population. Therefore, the decision makers should consider trade-offs between vaccination 
of the whole population or developing vaccination strategies only for refugees. If the whole population is vaccinated, 
there is a need of 3,851,749 polio vaccines, which cost 5,127,238 US$. The total number of vaccines decreases to 
337,980 with a cost of 845,238 US$, if only refugee children are vaccinated. Considering the occurrence rates of polio 
in Turkey and Syria in 2015 (three cases total), health care decision makers should decide the vaccination rates of the 
whole population and the risk groups for various ages.   
 
Table 3: Comparison of optimal number of vaccines and cost for different vaccination ratios  
  Only Refugees Whole Population 
Scenarios Vaccine quantity Cost ($) Vaccine quantity Cost ($) 
HRB 100%, LRB 100% 337,980  845,238 3,851,749    5,127,238 
HRB 95%, LRB 80% 287,312    743,892 3,461,054    4,592,674 
HRB 70%, LRB 80% 270,427    727,020 3,455,513    4,570,776 
HRB 90%, LRB 80% 281,671    721,328 3,334,506    4,429,052 
HRB 80%, LRB 80% 270,392    676,212 3,081,412    4,101,818 
HRB 80%, LRB 70% 247,873    636,804 2,949,331    3,916,327 
HRB: Minimum ratio of the individuals to be vaccinated in high risk age group (age 6); LRB: Minimum ratio of the individuals to be vaccinated in 
low risk age group (age 6+) 
 
We use the MIP model to compare the distribution strategies considering the groups changing by their a) region (city) 
only, and b) age only strategies. In the region only strategy, maximum number of the vaccinated individuals is the 
same and no priority for the age group is applied within a region. In this strategy, we compare the cost effectiveness 
of different amount of maximum vaccine quantities that are received by each location to vaccinate only refugees or 
the whole population. While considering the vaccination of the whole population, the maximum numbers of available 
vaccines for each city are limited by 800K; 700K; 600K; 500K; 400K; 300K and 200K, respectively. Figure 1 shows 
the total number of individuals vaccinated and the corresponding costs when the region only vaccination strategy is 
applied to the whole population. In this strategy, all cities have the same amount of maximum available vaccine 
quantities, and none of the locations has privilage over others. However, since the amounts available for each location 
are not in levels sufficient to the population size, some cities have vaccine shortages while others have excess 
inventory. Thus, the cost doesn’t increase linearly as the maximum amount of vaccines available for each city 
increases. Figure 2 shows the total number of individuals vaccinated and the corresponding costs when city only 
vaccination strategy is applied to refugees. In Figure 2, the maximum numbers of available vaccines are 100K; 90K; 
80K; 70K; 60K; 50K; 40K; 30K; 20K and 10K, respectively.  
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Figure 1: Cost of region only strategy applied to the whole population  
 
 
Figure 2: Cost of region only strategy applied to the refugees 
          
In the last part of the numerical study, we compare the cost effectiveness of age-based strategy and mix-strategy in 
which the maximum number of vaccines available for each city is distributed according to the population and the age-
based risk groups. As a base line, no age or region based constraints are included in the model; and the problem is 
solved considering various available vaccine quantities with the objective of vaccination cost minimization. Then, age 
based constraints are added into the baseline model. In the age-based strategy, the minimum ratio of the individuals 
vaccinated in the high risk age group is bounded by 80%. In the mix-strategy, in addition to the age based constraints, 
the population of the region is also considered. In this strategy, age constraints are included to guarantee that high risk 
age group is prioritized over others and, the minimum ratio of the individuals vaccinated in the high risk age group is 
also limited to 80% similar to the age-based strategy. Figure 3 presents the costs of each strategy.  
 
 
Figure 3: Comparison of aged-based and mix-strategy versus baseline 
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As seen in Figure 3, the minimum cost is achieved when there are no constraints. However, the baseline case does not 
prioritize the youngest population to be highly protected. In case of the mix-strategy, not only the age but also the 
population of each location is considered for distribution of the vaccine quantities. Because the population count is 
considered, the shortages and inventory levels are lower in comparison to the age-based strategy. Out of the three 
strategies, age-based strategy costs the highest due to the highest amount of shortages and excess inventory. 
4. Conclusion
Vaccination against polio is an effective strategy to prevent from outbreaks [4]. Thus, we consider the problem of 
polio vaccine quantity determination for each location and age group considering the vaccine history of the 
individuals. The goal of the developed model is to decide the optimal number of individuals in each location and age 
group to be vaccinated against polio in an effort to achieve a high level protection. Different vaccination strategies 
based on age, region, and the age-population (mix-strategy) are compared in cost effectiveness. These strategies are 
also compared for scenarios under the refugee only and the whole population vaccination policies. The mix-strategy, 
where the vaccines are distributed according to both the refugee population and the age-based constraints, satisfies the 
minimum cost strategy since the vaccine inventory costs and relevant shortages are relatively small. In the proposed 
model, the comparison of different vaccination strategies are only on the cost basis; however, risk analysis with 
respect to possible spread scenarios of polio should be integrated to the model. Furthermore, integrating the time 
horizon concept in the MIP model to eradicate the polio virus is another potential future study. 
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